期刊文献+

老年慢性阻塞性肺疾病患者的血清激活素A和转化生长因子β1与肺功能变化的相关性 被引量:7

Clinic significance and correlations of serum activin A,transforming growth factor beta 1 and pulmonary function of elderly patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨老年慢性阻塞性肺疾病(COPD)患者的血清激活素A(ACTA)和转化生长因子β1(TGF-β1)与肺功能变化的相关性。方法选择于2014年9月至2015年9月收治的老年COPD患者95例作为研究对象,选取同期60例健康体检者作为对照组。采用酶联免疫吸附法(ELISA)法检测血清ACTA和TGF-β1水平。采用Pearson相关性分析法分析ACTA和TGF-β1水平与各肺功能指标的相关性。结果与健康对照组相比,老年COPD患者的ACTA和TGF-β1水平显著升高(P<0.05)。COPD严重程度越高,ACTA和TGF-β1水平越高(P<0.05)。肺功能损伤等级越高,ACTA和TGF-β1水平随之显著增高(P<0.05)。Pearson相关性分析结果显示,老年COPD患者血清ACTA和TGF-β1与FEV1%呈显著负相关(r=-0.687,-0.751,P<0.05),血清ACTA和TGF-β1与FEV1/FVC呈显著负相关(r=-0.613,-0.598,P<0.05)。结论 ACTA和TGF-β1在老年COPD患者的病情进展中具有重要作用,且与肺功能变化具有相关性。 Objective To explore the clinic significance and correlations of serum activin A,transforming growth factor β1 and pulmonary function of elderly patients with chronic obstructive pulmonary disease. Methods 95 patients with elderly COPD were collected as the research object from September 2014 to September 2015. Sixty healthy subjects served as controls. The concentrations of ACTA and TGF- β1 were determined using ELISA. The pearson correlation test was performed to analyze the correlation between ACTA,TGF- β1 and pulmonary function index. Results Compared with those in healthy controls,plasma ACTA and TGF- β1 levels in elderly COPD increased significantly( P〈0. 05).The higher of the COPD level,the higher the level of ACTA and TGF- beta 1( P〈0. 05). The higher the level of pulmonary function damage,the higher the level of ACTA and TGF- beta 1. Pearson correlation analysis showed that the serum levels of ACTA,TGF- β1 were negatively correlated with FEV1%( r =- 0. 687,- 0. 751,P〈0. 05),and they were also negatively correlated with FEV1 / FVC( r =- 0. 613,- 0. 598,P〈0. 05). Conclusion ACTA and TGF- β1 play important roles in the progression of COPD,and have correlation with pulmonary function changes.
作者 樊晓曦
出处 《临床和实验医学杂志》 2016年第10期975-977,共3页 Journal of Clinical and Experimental Medicine
关键词 老年人 慢性阻塞性肺疾病 血清激活素A 转化生长因子Β1 肺功能 Elderly COPD ACTA TGF-β1 Pulmonary function
  • 相关文献

参考文献13

  • 1Ganesan S, Unger BL, Comstock AT, et al. Aberrantly activated EGFR contributes to enhanced IL -8expression in COPD airways epithelial cells via regulation of nuclear FoxO3A[ J]. Thorax, 2013, 68(2) :131 -141.
  • 2Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease [ J]. Annu Rev Pathol, 2009,4 ( 1 ) :435 - 459.
  • 3Lee H, Kim J, Tagmazyan K. Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines [ J ]. Am Fam Physician, 2013,88 (10) :655 - 663.
  • 4慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2054
  • 5Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dysp- nea. Contents, interobserver agreement, and physiologic correlates of two newclinical indexes[J]. Chest, 1984,85 (6) :751 - 758.
  • 6沙悦,曾学军,韩江娜.慢性阻塞性肺疾病的呼吸困难[J].国际呼吸杂志,2013,33(1):48-52. 被引量:13
  • 7Van Bruaene N, C PN, Van Cmmbruggen K, et al. Inflammation and remodeling patterns in early stage chronic rhinosinusitis [ J ]. Clin Exp Allergy, 2012,42(6) :883 -890.
  • 8Hedger MP, Winnall WR, Phillips DJ, et 8]. The regulation and func- tions of activin and follistatin in inflammation and immunity[ J]. Vitam Horm, 2011,85:255 -297.
  • 9Santibanez JF, Quintanilla M, Bernabeu C. TGF - beta/TGF - beta re- ceptor system and its role in physiological and pathological conditions [J]. ClinSci (Lond), 2011,121(6) :233 -251.
  • 10Gong Y, Fan L, Wan H, et al. Lack of association between the TGF - 131 gene and development of COPD in asians:a case - control study and meta - analysis [ J ]. Lung, 2011,189 ( 3 ) : 213 - 223.

二级参考文献25

  • 1柳涛,蔡柏蔷.一种新型的生活质量评估问卷:慢性阻塞性肺疾病评估测试[J].中国医学科学院学报,2010,32(2):234-238. 被引量:164
  • 2姚婉贞,朱红,沈宁,韩翔,梁岩静,张立强,孙永昌,郝振婷,赵鸣武.无症状慢性阻塞性肺疾病患者特点分析[J].中华结核和呼吸杂志,2005,28(8):513-515. 被引量:33
  • 3冉丕鑫,王辰,姚婉贞,陈萍,康健,黄绍光,陈宝元,王长征,倪殿涛,周玉民,刘升明,王小平,王大礼,吕嘉春,郑劲平,钟南山.体重指数与慢性阻塞性肺疾病及生活质量的关系[J].中华结核和呼吸杂志,2007,30(1):18-22. 被引量:82
  • 4蔡闯,钟南山.慢性阻塞性肺疾病与焦虑抑郁的关系[J].中华结核和呼吸杂志,2007,30(1):71-72. 被引量:81
  • 5Rutten FH,Hoes AW.Chronic obstructive pulmonarydisease:a slowly progressive cardiovascular diseasemasked by its pulmonary effects [J].Eur J Heart Fail,2012,14(4):348-350.
  • 6Metzger NL,Lundquist LM.A review of the advances inchronic obstructive pulmonary disease treatment [ J].JPharmacy Practice,2012,25(12):576-582.
  • 7Miravitlles M.Prevention of exacerbations of COPD withpharmacotherapy[J].Eur Respir Rev,2010,19(1):119-126.
  • 8Kim V,Criner GJ.Chronic Bronchitis and Chronic Ob-structive Pulmonary Disease[J]. Am J Respir Crit Care Med,2013,187(2):228-237.
  • 9Cisneros J,Montano M,Rivera RM,et al.Analysis of cy-tokines and gelatinases in a rat model combining metabolicsyndrome and chronic obstructive pulmonary diseases(COPD)[J].Am J Respir Crit Care Med,2011,183(5):669-672.
  • 10Mat Z,Grensemann B,Yakin Y,et al.Effect of lipotei-choic acid on IL-2 and IL-5 release from T lymphocytes inasthma and COPD[J].Int Immunopharmacol,2012,13(3):284-291.

共引文献2089

同被引文献89

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部